Azitra (AZTR) Current Taxes (2024 - 2025)
Azitra (AZTR) posted Current Taxes of $6256.0 for Q4 2025, down 45.94% on a QoQ basis from $11572.0 in Q4 2024, and down 45.94% year-over-year from $11572.0 in Q4 2024.
Azitra (AZTR) Current Taxes (2024 - 2025) Analysis & Trends
Azitra's Current Taxes history runs 2 years deep, the most recent figure standing at $6256.0 for Q4 2025.
- Quarterly Current Taxes fell 45.94% year-over-year to $6256.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6256.0 (down 45.94% YoY) and the FY2025 annual result came in at $6256.0, down 45.94% from the prior year.
- Current Taxes was $6256.0 for Q4 2025 at Azitra, down from $11572.0 in the prior quarter.
- Across five years, Current Taxes topped out at $11572.0 in Q4 2024 and bottomed at $6256.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,769.80 Bn | 1,769.74 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.64 Bn | 468.85 Bn | 1.35 Bn | 63.52 Mn |
| 4 | Vertex Pharmaceuticals | 123.74 Bn | 116.49 Bn | 2.59 Bn | - |
| 5 | Regeneron Pharmaceuticals | 71.73 Bn | 62.97 Bn | 3.31 Bn | - |
| 6 | Belite Bio | 62.10 Bn | 62.10 Bn | - | - |
| 7 | Argenx Se | 54.68 Bn | 49.49 Bn | 1.41 Bn | 49.00 Mn |
| 8 | Alnylam Pharmaceuticals | 38.13 Bn | 35.12 Bn | 959.66 Mn | - |
| 9 | Revolution Medicines | 36.21 Bn | 36.21 Bn | - | - |
| 10 | Azitra | 2.03 Mn | 2.03 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6,256.00 |
| Dec 31, 2024 | 11,572.00 |